E2F1 and E2F7 differentially regulate KPNA2 to promote the development of gallbladder cancer

Shanshan Xiang, Zheng Wang, Yuanyuan Ye, Fei Zhang, Huaifeng Li, Yang Yang, Huijie Miao, Haibin Liang, Yijian Zhang, Lin Jiang, Yunping Hu, Lei Zheng, Xiyong Liu, Yingbin Liu

Research output: Contribution to journalArticle

Abstract

Karyopherin alpha 2 (KPNA2) is a nuclear import factor that is elevated in multiple cancers. However, its molecular regulation at the transcriptional levels is poorly understood. Here we found that KPNA2 was significantly upregulated in gallbladder cancer (GBC), and the increased levels were correlated with short survival of patients. Gene knocking down of KPNA2 inhibited tumor cell proliferation and migration in vitro as well as xenografted tumor development in vivo. A typical transcription factor E2F1 associated with its DNA-binding partner DP1 bond to the promoter region of KPNA2 and induced KPNA2 expression. In contrast, an atypical transcription factor E2F7 competed against DP1 and blocked E2F1-induced KPNA2 gene activation. Mutation of the dimerization residues of E2F7 or DNA-binding domain of E2F1 abolished the suppressive effects of E2F7 on KPNA2 gene expression. In addition, KPNA2 mediated nuclear localization of E2F1 and E2F7, where they in turn controlled KPNA2 expression. Taken together, our data provided mechanistic insights into divergently transcriptional regulation of KPNA2, thus pointing to KPNA2 as a potential target for cancer therapy.

Original languageEnglish (US)
Pages (from-to)1269-1281
Number of pages13
JournalOncogene
Volume38
Issue number8
DOIs
StatePublished - Feb 21 2019

Fingerprint

Gallbladder Neoplasms
E2F7 Transcription Factor
Neoplasms
karyopherin alpha 2
E2F1 Transcription Factor
Cell Nucleus Active Transport
DNA
Dimerization
Genetic Promoter Regions
Transcriptional Activation
Cell Movement
Cell Proliferation

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research

Cite this

Xiang, S., Wang, Z., Ye, Y., Zhang, F., Li, H., Yang, Y., ... Liu, Y. (2019). E2F1 and E2F7 differentially regulate KPNA2 to promote the development of gallbladder cancer. Oncogene, 38(8), 1269-1281. https://doi.org/10.1038/s41388-018-0494-7

E2F1 and E2F7 differentially regulate KPNA2 to promote the development of gallbladder cancer. / Xiang, Shanshan; Wang, Zheng; Ye, Yuanyuan; Zhang, Fei; Li, Huaifeng; Yang, Yang; Miao, Huijie; Liang, Haibin; Zhang, Yijian; Jiang, Lin; Hu, Yunping; Zheng, Lei; Liu, Xiyong; Liu, Yingbin.

In: Oncogene, Vol. 38, No. 8, 21.02.2019, p. 1269-1281.

Research output: Contribution to journalArticle

Xiang, S, Wang, Z, Ye, Y, Zhang, F, Li, H, Yang, Y, Miao, H, Liang, H, Zhang, Y, Jiang, L, Hu, Y, Zheng, L, Liu, X & Liu, Y 2019, 'E2F1 and E2F7 differentially regulate KPNA2 to promote the development of gallbladder cancer', Oncogene, vol. 38, no. 8, pp. 1269-1281. https://doi.org/10.1038/s41388-018-0494-7
Xiang, Shanshan ; Wang, Zheng ; Ye, Yuanyuan ; Zhang, Fei ; Li, Huaifeng ; Yang, Yang ; Miao, Huijie ; Liang, Haibin ; Zhang, Yijian ; Jiang, Lin ; Hu, Yunping ; Zheng, Lei ; Liu, Xiyong ; Liu, Yingbin. / E2F1 and E2F7 differentially regulate KPNA2 to promote the development of gallbladder cancer. In: Oncogene. 2019 ; Vol. 38, No. 8. pp. 1269-1281.
@article{c356b18a7e4540b19690992076db1199,
title = "E2F1 and E2F7 differentially regulate KPNA2 to promote the development of gallbladder cancer",
abstract = "Karyopherin alpha 2 (KPNA2) is a nuclear import factor that is elevated in multiple cancers. However, its molecular regulation at the transcriptional levels is poorly understood. Here we found that KPNA2 was significantly upregulated in gallbladder cancer (GBC), and the increased levels were correlated with short survival of patients. Gene knocking down of KPNA2 inhibited tumor cell proliferation and migration in vitro as well as xenografted tumor development in vivo. A typical transcription factor E2F1 associated with its DNA-binding partner DP1 bond to the promoter region of KPNA2 and induced KPNA2 expression. In contrast, an atypical transcription factor E2F7 competed against DP1 and blocked E2F1-induced KPNA2 gene activation. Mutation of the dimerization residues of E2F7 or DNA-binding domain of E2F1 abolished the suppressive effects of E2F7 on KPNA2 gene expression. In addition, KPNA2 mediated nuclear localization of E2F1 and E2F7, where they in turn controlled KPNA2 expression. Taken together, our data provided mechanistic insights into divergently transcriptional regulation of KPNA2, thus pointing to KPNA2 as a potential target for cancer therapy.",
author = "Shanshan Xiang and Zheng Wang and Yuanyuan Ye and Fei Zhang and Huaifeng Li and Yang Yang and Huijie Miao and Haibin Liang and Yijian Zhang and Lin Jiang and Yunping Hu and Lei Zheng and Xiyong Liu and Yingbin Liu",
year = "2019",
month = "2",
day = "21",
doi = "10.1038/s41388-018-0494-7",
language = "English (US)",
volume = "38",
pages = "1269--1281",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - E2F1 and E2F7 differentially regulate KPNA2 to promote the development of gallbladder cancer

AU - Xiang, Shanshan

AU - Wang, Zheng

AU - Ye, Yuanyuan

AU - Zhang, Fei

AU - Li, Huaifeng

AU - Yang, Yang

AU - Miao, Huijie

AU - Liang, Haibin

AU - Zhang, Yijian

AU - Jiang, Lin

AU - Hu, Yunping

AU - Zheng, Lei

AU - Liu, Xiyong

AU - Liu, Yingbin

PY - 2019/2/21

Y1 - 2019/2/21

N2 - Karyopherin alpha 2 (KPNA2) is a nuclear import factor that is elevated in multiple cancers. However, its molecular regulation at the transcriptional levels is poorly understood. Here we found that KPNA2 was significantly upregulated in gallbladder cancer (GBC), and the increased levels were correlated with short survival of patients. Gene knocking down of KPNA2 inhibited tumor cell proliferation and migration in vitro as well as xenografted tumor development in vivo. A typical transcription factor E2F1 associated with its DNA-binding partner DP1 bond to the promoter region of KPNA2 and induced KPNA2 expression. In contrast, an atypical transcription factor E2F7 competed against DP1 and blocked E2F1-induced KPNA2 gene activation. Mutation of the dimerization residues of E2F7 or DNA-binding domain of E2F1 abolished the suppressive effects of E2F7 on KPNA2 gene expression. In addition, KPNA2 mediated nuclear localization of E2F1 and E2F7, where they in turn controlled KPNA2 expression. Taken together, our data provided mechanistic insights into divergently transcriptional regulation of KPNA2, thus pointing to KPNA2 as a potential target for cancer therapy.

AB - Karyopherin alpha 2 (KPNA2) is a nuclear import factor that is elevated in multiple cancers. However, its molecular regulation at the transcriptional levels is poorly understood. Here we found that KPNA2 was significantly upregulated in gallbladder cancer (GBC), and the increased levels were correlated with short survival of patients. Gene knocking down of KPNA2 inhibited tumor cell proliferation and migration in vitro as well as xenografted tumor development in vivo. A typical transcription factor E2F1 associated with its DNA-binding partner DP1 bond to the promoter region of KPNA2 and induced KPNA2 expression. In contrast, an atypical transcription factor E2F7 competed against DP1 and blocked E2F1-induced KPNA2 gene activation. Mutation of the dimerization residues of E2F7 or DNA-binding domain of E2F1 abolished the suppressive effects of E2F7 on KPNA2 gene expression. In addition, KPNA2 mediated nuclear localization of E2F1 and E2F7, where they in turn controlled KPNA2 expression. Taken together, our data provided mechanistic insights into divergently transcriptional regulation of KPNA2, thus pointing to KPNA2 as a potential target for cancer therapy.

UR - http://www.scopus.com/inward/record.url?scp=85053816988&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053816988&partnerID=8YFLogxK

U2 - 10.1038/s41388-018-0494-7

DO - 10.1038/s41388-018-0494-7

M3 - Article

C2 - 30254209

AN - SCOPUS:85053816988

VL - 38

SP - 1269

EP - 1281

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 8

ER -